仿ãAVBPã¯7ä»¶ã®ãè²·ããã0ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããAVBPã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯44.909ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS -1.048ã«ç¶ããAVBPã®FY2026Q3ã®EPSã¯-1.069ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD -1.05 ã§ããããArrivent Biopharma IncAVBP ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.96 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -1.07 ãšäºæ³ãããŸãã